This suggests that alkyl- and alkenyl-EL could control the expression of SK3 within these organs and could explain part of the neurodegenerative and cardiovascular diseases observed when EL quantities are decreased in these pathologies (5). The gene discussed is KCNN3; the disease is cardiovascular disorder.